Quality of Life Analysis of Treatment in Patients With Prostate Cancer on Adjuvant Zoladex Therapy

Quality of Life Analysis of Prostate Cancer Patient's Therapy

This is an open label, non-interventional quality of life analysis for Zoladex treated prostate cancer patients by investigator's questionnaire

Inclusion Criteria:

• Provision of informed consent
• Early or locally-advanced prostate cancer patients on androgen deprivation therapy
• Investigators are requested to recruit patients only with at least 1 month prior Zoladex treatment.

Exclusion Criteria:

• Allergy to substance of medication
• Prostate cancer patients with advanced disease